Literature DB >> 315842

Quantitation and characterization of soluble immune complexes precipitated from sera by polyethylene glycol (PEG).

D Chia, E V Barnett, J Yamagata, D Knutson, C Restivo, D Furst.   

Abstract

Polyethylene glycol (PEG) was used to isolate immune complexes from sera. Complexes were then quantified and partially characterized by a variety of immunological techniques. Complexes were detected in rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), Felty's syndrome and vasculitis, but not in polymyositis, scleroderma or Behçets syndrome. The level of immune complexes correlated with disease activity in SLE and RA patients. Rheumatoid factors and anti-DNA antibodies were enriched by PEG precipitation of RA and SLE sera, respectively, thus these antibodies appeared to be present in the form of soluble immune complexes. Immune complexes usually contained all three immunoglobulin classes, IgG, IgM and IgA. Complexes from RA patients were generally larger and often contained Clq, while C3 was found almost exclusively in SLE complexes which also tended to be smaller. Such compositional differences may one day explain the differences in clinical manifestations of various immune complex-mediated diseases.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 315842      PMCID: PMC1537790     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  16 in total

1.  Correlation of natural antibodies to nuclear substances in New Zealand and other strains of mouse.

Authors:  C Abe; D Chia; E V Barnett; C M Pearson; E A Hays; Y Shiokawa
Journal:  Clin Immunol Immunopathol       Date:  1976-11

2.  1958 Revision of diagnostic criteria for rheumatoid arthritis.

Authors:  M W ROPES; G A BENNETT; S COBB; R JACOX; R A JESSAR
Journal:  Bull Rheum Dis       Date:  1958-12

3.  Immunology of DNA. VI. The effect of mercaptans on IgG and IgM anti-dsDNA.

Authors:  L A Aarden; F Lakmaker; E De Groot
Journal:  J Immunol Methods       Date:  1977       Impact factor: 2.303

4.  Ultracentrifugal studies of the reactions of rheumatoid factor with native human gamma-G-globulin.

Authors:  D E Normansell; D R Stanworth
Journal:  Immunology       Date:  1966-06       Impact factor: 7.397

5.  Precipitation of some plasma proteins by the addition of dextran or polyethylene glycol.

Authors:  P H Iverius; T C Laurent
Journal:  Biochim Biophys Acta       Date:  1967-02-21

6.  Circulating immune complexes detected by 125I-Clq deviation test in sera of cancer patients.

Authors:  H Teshima; H Wanebo; C Pinsky; N K Day
Journal:  J Clin Invest       Date:  1977-06       Impact factor: 14.808

7.  Detection of immune complexes. The use of radioimmunoassays with Clq and monoclonal rheumatoid factor.

Authors:  A Gabriel; V Agnello
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808

8.  Avidity of anti-DNA antibodies in serum and IgG glomerular eluates from patients with systemic lupus erythematosus. Association of high avidity antinative DNA antibody with glomerulonephritis.

Authors:  J B Winfield; I Faiferman; D Koffler
Journal:  J Clin Invest       Date:  1977-01       Impact factor: 14.808

9.  Detection of circulating IgG aggregates and immune complexes using 125I protein A from Staphylococcus aureus.

Authors:  R Hällgren; L Wide
Journal:  Ann Rheum Dis       Date:  1976-08       Impact factor: 19.103

10.  A double-blind trial of high versus conventional dosages of gold salts for rheumatoid arthritis.

Authors:  D E Furst; S Levine; R Srinivasan; A L Metzger; R Bangert; H E Paulus
Journal:  Arthritis Rheum       Date:  1977 Nov-Dec
View more
  23 in total

1.  C3-containing serum immune complexes in patients with systemic lupus erythematosus: correlation to disease activity and comparison with other rheumatic diseases.

Authors:  C Huber; A Rüger; M Herrmann; F Krapf; J R Kalden
Journal:  Rheumatol Int       Date:  1989       Impact factor: 2.631

2.  Simultaneous analysis of eighteen proteins in the sera and knee joint effusions of patients with rheumatoid arthritis and osteoarthritis.

Authors:  D Wiedermann; V Vitulová
Journal:  Clin Rheumatol       Date:  1986-09       Impact factor: 2.980

3.  Trichinella spiralis--characterization of circulating and immune-complex-associated antigens.

Authors:  V K Todorova; C V Tankov; T V Dimitrov
Journal:  Parasitol Res       Date:  1993       Impact factor: 2.289

4.  Interaction of immune complexes and T suppressor cells in sarcoidosis.

Authors:  J D Williams; M D Smith; B H Davies
Journal:  Thorax       Date:  1982-08       Impact factor: 9.139

5.  Detection of specific antigen within circulating immune complexes: validation of the assay and its application to food antigen-antibody complexes formed in healthy and food-allergic subjects.

Authors:  R Paganelli; R J Levinsky; D J Atherton
Journal:  Clin Exp Immunol       Date:  1981-10       Impact factor: 4.330

6.  IgG aggregates of different sizes stimulate or suppress Ig secretion by human lymphocytes in vitro.

Authors:  C Wiesenhutter; D W Knutson; D S Musgrave; R F Ashman
Journal:  J Clin Immunol       Date:  1984-03       Impact factor: 8.317

7.  Immunoblotting identifies an antigen recognized by anti gp63 in the immune complexes of Indian kala-azar patient sera.

Authors:  T Sanyal; D K Ghosh; D Sarkar
Journal:  Mol Cell Biochem       Date:  1994-01-12       Impact factor: 3.396

8.  Characterization of DNA in polyethylene glycol precipitated immune complexes from sera of patients with systemic lupus erythematosus.

Authors:  K Ikebe; R C Gupta; E M Tan
Journal:  Clin Exp Immunol       Date:  1983-10       Impact factor: 4.330

9.  Detection of circulating free and complexed staphylococcal antigens by enzyme-linked immunosorbent assay.

Authors:  J R Lentino; M W Rytel
Journal:  J Clin Microbiol       Date:  1982-12       Impact factor: 5.948

10.  Impaired response of neutrophils to a lymphokine by sera from patients with connective tissue disease.

Authors:  H M Kenney; R H Weisbart; K K Colburn; C K Abrass; E V Barnett; D W Golde
Journal:  Infect Immun       Date:  1983-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.